Plain language summary about tirabrutinib in relapsed/refractory primary central nervous system lymphoma.

Sugiyama K, Narita Y, Nagane M, Mishima K, Terui Y, Arakawa Y, Asai K, Fukuhara N, Yonezawa H, Shinojima N, Aoi A, Nishikawa R

Open source

DOI: 10.1080/14796694.2025.2574838
Published: 2025 Nov
Container: Future oncology (London, England)
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1080/14796694.2025.2574838,
  title = {Plain language summary about tirabrutinib in relapsed/refractory primary central nervous system lymphoma.},
  author = {Sugiyama K and Narita Y and Nagane M and Mishima K and Terui Y and Arakawa Y and Asai K and Fukuhara N and Yonezawa H and Shinojima N and Aoi A and Nishikawa R},
  year = {2025},
  journal = {Future oncology (London, England)},
  doi = {10.1080/14796694.2025.2574838},
  url = {https://doi.org/10.1080/14796694.2025.2574838}
}

RIS

TY  - JOUR
TI  - Plain language summary about tirabrutinib in relapsed/refractory primary central nervous system lymphoma.
AU  - Sugiyama K
AU  - Narita Y
AU  - Nagane M
AU  - Mishima K
AU  - Terui Y
AU  - Arakawa Y
AU  - Asai K
AU  - Fukuhara N
AU  - Yonezawa H
AU  - Shinojima N
AU  - Aoi A
AU  - Nishikawa R
PY  - 2025
JO  - Future oncology (London, England)
DO  - 10.1080/14796694.2025.2574838
UR  - https://doi.org/10.1080/14796694.2025.2574838
ER  -

APA

K, S., Y, N., M, N., K, M., Y, T., Y, A., K, A., N, F., H, Y., N, S., A, A., & R, N. (2025). Plain language summary about tirabrutinib in relapsed/refractory primary central nervous system lymphoma.. Future oncology (London, England). https://doi.org/10.1080/14796694.2025.2574838

Source records

pubmed · retrieved 2026-09-26T21:04:59.915Z